The global therapeutic vaccines market is poised to grow by $3.78 billion during 2020-2024 progressing at a CAGR of 43% during the forecast period.
This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
The market is driven by the rising incidence and prevalence of diseases, strong therapeutic vaccine pipeline, and increasing funding for the development of vaccines. The study identifies the increase in R&D activities related to novel therapeutic vaccines as one of the prime reasons driving the therapeutic vaccines market growth during the next few years. Also, initiatives to increase awareness about severe diseases and rise in number of strategic alliances will lead to sizable demand in the market.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading therapeutic vaccines market vendors that include:
Advantagene Inc.
Aimmune Therapeutics Inc.
Amgen Inc.
Gilead Sciences Inc.
Immune Response BioPharma Inc.
Inovio Pharmaceuticals Inc.
Merck & Co. Inc.
Novartis AG
Sanpower Group Co. Ltd.
SOTIO AS
Also, the therapeutic vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Key Topics Covered
1. Executive Summary
Market Overview
2. Market Landscape
Market ecosystem
Value chain analysis
3. Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019-2024
4. Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
5. Market Segmentation by Type
Market segments
Comparison by Type
Cancer vaccines - Market size and forecast 2019-2024
Infectious diseases vaccines - Market size and forecast 2019-2024
Neurological diseases vaccines - Market size and forecast 2019-2024
Autoimmune diseases vaccines - Market size and forecast 2019-2024
Other diseases vaccines - Market size and forecast 2019-2024
Market opportunity by Type
6. Customer Landscape
Customer landscape
7. Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...